Intramuscular Pentazocine and Rectal Diclofenac for pain relief during Manual Vacuum Aspiration (MVA): A randomized control trial in Dalhatu Araf Specialist Hospital, Lafia, Nigeria.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202511523585786

Enrollment

100

Registered

2025-11-19

Start date

2022-07-24

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of incomplete miscarriage

Interventions

Rectal Diclofenac

Intramuscular Pentazocine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Women with first trimester incomplete abortion clinical and or ultrasound confirmation of pregnancy. 2) Haemodynamically stable women. 3) Women who consented to the study with gestational age up to 12 weeks.

Exclusion criteria

Exclusion criteria: 1) Women with allergy or contraindication to either Pentazocine or Diclofenac. 2) Patients with severe illnesses or co-morbidity like severe anaemia, sepsis, uterine perforation. 3) Women with active infection such as abortion. 4) Women who decline consent.

Design outcomes

Primary

Measure	Time frame
Pain intensity as measured using Visual analogue scale.	—

Secondary

Measure	Time frame
Participants satisfaction with mode of treatment (route of administration) and pain intensity Side effect profile	—

Countries

Nigeria

Contacts

Public ContactLucky Changkat

Consultant and researcher

llohnan@gmail.com+2348024206010

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026